Reply to: "Predictors of sorafenib benefit in patients with hepatocellular carcinoma".
作者信息
Bruix Jordi, Lii Cheng Ann, Llovet Josep
机构信息
BCLC Hospital Clínic Barcelona, IDIBAPS, University of Barcelona CIBERehd, Barcelona, Spain.
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
出版信息
J Hepatol. 2018 Mar;68(3):620-621. doi: 10.1016/j.jhep.2017.10.013. Epub 2017 Oct 24.
PMID:29079287
Abstract
摘要
Zotero 插件